The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Anurag Bajpayee, Founder and CEO, Gradiant
Senior executives from TOTAL will be visiting MIT from Oct 8-10 for the purpose of exploring potential partnerships with MIT startups. The goal of October’s visit is to meet experts that can help to find the best way to enhance Data Management (DM) practices throughout TOTAL entities. Data must be managed effectively and valued to maximize its business impact. Attendees from TOTAL include Michel Lutz, Group Data Officer, and Gaile Lejay, Business analyst.